Speaker illustration

Doctor Noreen Butt

Stavanger University Hospital, Stavanger (Norway)

Peri-procedural treatment with high dose Rosuvastatin reduces soluble TNF receptor 1 in patients treated with primary percutaneous coronary intervention for ST elevation myocardial infarction

Event: ESC Congress 2019

Topic: Inflammation

Session: Acute coronary syndromes, coronary artery disease: treatment


Infusion of TRO40303 in patients with ST-elevation myocardial infarction prior to primary percutaneous coronary intervention did not alter levels of inflammatory biomarkers in the MITOCARE study

Event: ESC Congress 2016

Topic: Adjunctive medical therapy

Session: Adjunctive medical therapy in coronary artery disease


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb